Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4599 Target Snapshot

Activated CDC42 kinase 1 · SINGLE PROTEIN · Homo sapiens

2,139Compounds
344Assays
30Approved Drugs
1,572.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q07912. Use UniProt Q07912 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q07912 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Activated CDC42 kinase 1 as ChEMBL target CHEMBL4599, mapped to UniProt Q07912. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Activated CDC42 kinase 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4599
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q07912
Activated CDC42 kinase 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Activated CDC42 kinase 1 is the right protein anchor across sources, using UniProt Q07912 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelActivated CDC42 kinase 1
UniProt AccessionQ07912
Component TypeProtein
Sequence Length1038 aa

Activated CDC42 kinase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Activated CDC42 kinase 1, mapped to UniProt Q07912. Sequence length is 1038 aa.

Mapped IDQ07912
Review nameActivated CDC42 kinase 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

30
Approved
3
Phase III
16
Phase II
12
Phase I
Assay Mix

Activity Type Distribution

IC50741.0
KI444.0
KD387.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5400397 9.7 IC50 0.2 Preclinical
CHEMBL2087874 9.7 Ki 0.2 Preclinical
CHEMBL5408748 9.52 IC50 0.3 Preclinical
CHEMBL5431206 9.52 IC50 0.3 Preclinical
CHEMBL2087875 9.52 Ki 0.3 Preclinical
CHEMBL2087873 9.52 Ki 0.3 Preclinical
CHEMBL5409024 9.4 IC50 0.4 Preclinical
CHEMBL5398945 9.22 IC50 0.6 Preclinical
CHEMBL5419830 9.22 IC50 0.6 Preclinical
CHEMBL5428907 9.22 IC50 0.6 Preclinical
Distribution

pChEMBL Value Distribution

108
5.0
131
5.5
143
6.0
134
6.5
128
7.0
111
7.5
79
8.0
49
8.5
14
9.0
7
9.5
pChEMBL
Approved Drugs

Approved Drugs

ENTRECTINIB
CHEMBL1983268
Approved 2019
FEDRATINIB
CHEMBL1287853
Approved 2019
LORLATINIB
CHEMBL3286830
Approved 2018
LAROTRECTINIB
CHEMBL3889654
Approved 2018
MIDOSTAURIN
CHEMBL608533
Approved 2017
NERATINIB
CHEMBL180022
Approved 2017
OSIMERTINIB
CHEMBL3353410
Approved 2015
CERITINIB
CHEMBL2403108
Approved 2014
BOSUTINIB
CHEMBL288441
Approved 2012
VEMURAFENIB
CHEMBL1229517
Approved 2011
CRIZOTINIB
CHEMBL601719
Approved 2011
DASATINIB
CHEMBL5416410
Approved 2006
Assay Landscape

Assay Landscape

344
Total Assays
707
Tested Compounds
2
Assay Types
Binding — 342 assays, 707 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 236 500 6.6
cell-based format 55 116 7.9
assay format 36 63 7.0
subcellular format 15 28 6.3
Functional — 2 assays, 116 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 115 6.1
cell-based format 1 1 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine